Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Nouri Neamati

Matched on ORCID iD 0000-0003-3291-7131; OpenAlex author ID A5023220693; NIH RePORTER profile ID 6663522. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 12)
Trials
0
Grants
3
Labs led
2
Collaborators
21
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 2 papers, 1 grant · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers, 1 grant · 2024: none · 2025: 1 paper · 2026: 1 grant

Papers 14

  1. Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.4c03159↗
  2. Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.2c01769↗
  3. First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acsptsci.3c00069↗
  4. Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.1c01934↗
  5. Induction of Genes Implicated in Stress Response and Autophagy by a Novel Quinolin-8-yl-nicotinamide QN523 in Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.1c02207↗
  6. The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer. Last author DOI 10.1158/0008-5472.can-20-1540↗
  7. Discovery of Mitochondrial Transcription Inhibitors Active in Pancreatic Cancer Cells. Last author DOI 10.1002/cmdc.202000494↗
  8. UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Co-author DOI 10.1016/j.tranon.2020.100834↗
  9. Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines. Last author DOI 10.1016/j.ejmech.2018.09.037↗
  10. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1021/acs.jmedchem.7b01463↗
  11. Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jmedchem.5b01571↗
  12. Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells. Last author DOI 10.1111/bph.12855↗
  13. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer. Last author DOI 10.1016/j.bbagen.2013.08.005↗
  14. Mechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0054346↗

Grants 3

  1. Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer R01CA272641↗
  2. Targeting the RNA Exosome for Cancer Therapeutics R01CA213214↗
  3. ROS-targeted therapy for pancreatic cancer R01CA188252↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mats E. Ljungman · 7 shared papers, 1 shared grant, 2018–2023 · strength 1.51
  2. Yibin Xu · 5 shared papers, 2020–2025 · strength 0.95
  3. Joyeeta Roy · 4 shared papers, 2022–2025 · strength 0.84
  4. Duxin Sun · 3 shared papers, 2022–2025 · strength 0.64
  5. Vaibhav Sahai · 1 shared grant, 2023 · strength 0.61
  6. Ding Xue · 3 shared papers, 2021–2023 · strength 0.51
  7. Yuting Kuang · 3 shared papers, 2015–2021 · strength 0.31
  8. Mario Sechi · 4 shared papers, 2014–2018 · strength 0.29
  9. Divya Pathania · 3 shared papers, 2014–2016 · strength 0.18
  10. Yuting Kuang · 1 shared paper, 2022 · strength 0.15
  11. Amy Shiu Lee · 1 shared paper, 2021 · strength 0.13
  12. Soma Samanta · 1 shared paper, 2021 · strength 0.13
  13. Vanna Sanna · 2 shared papers, 2014–2016 · strength 0.11
  14. Wen‐Ming Chen · 1 shared paper, 2020 · strength 0.11
  15. Shuai Hu · 1 shared paper, 2018 · strength 0.11
  16. Theodore Steven Lawrence · 1 shared paper, 2020 · strength 0.09
  17. Alnawaz Rehemtulla · 1 shared paper, 2020 · strength 0.09
  18. Meredith Ann Morgan · 1 shared paper, 2020 · strength 0.09
  19. Carl G. Engelke · 1 shared paper, 2020 · strength 0.09
  20. Yajing Liu · 1 shared paper, 2020 · strength 0.09
  21. Yumna Shabaik · 1 shared paper, 2013 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.